Risks factors for the development of diabetes in women with history of gestational diabetes mellitus;Czynniki ryzyka zaburzeń gospodarki wȩglowodanowej u kobiet po przebytej cukrzycy ciȩżarnych

Polski Merkuriusz Lekarski

Volumn 18, Issue 103, 2005, Pages 70-73

  Cypryk, Katarzyna ^a   Szymczak, Wiesław ^b   Pertyńska Marczewska, Magdalena ^a   Zawodniak Szałapska, Małgorzata ^a   Lewiński, Andrzej ^a  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^b NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

Gestational diabetes mellitus; Risk factors; Type 1 diabetes; Type 2 diabetes

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY; PREGNANCY DIABETES MELLITUS; RISK ASSESSMENT; RISK FACTOR;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MIDDLE AGED; PREGNANCY; RISK FACTORS;

EID: 13444288302     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Raport Grupy Konsultacyjnej WHO - Definition, diagnosis and classification of diabetes mellitus and its compilations. Geneva 1999. (WHO/NCD/ NCS/99) - wersja polska. Med. Prakt., 2000, 1, 2, 85-109.
2. Bannet-Conor E., Cohn B., Wingard D.L.: Why is diabetes mellitus a stronger risk factor for ischaemic heart disease in women than in men? The Rancho Bernardo Study. JAMA, 1991, 265, 5, 627-631.
3. Buchanan T.A., Xiang A.H., Kjos S.L. i wsp.: Gestational diabetes, antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in latino women. Diabetes, 1998, 47, 8, 1302-1310.
4. Buchanan T.A., Xiang A.H, Kjos S.L. i wsp.: Antepartum predictors of the development of type 2 diabetes in latino women 11-26 months after prognancies complicated by gestational diabetes. Diabetes, 1999, 48, 12, 2430-2436.
5. Buchanan T.A., Xiang A.H, Peters R.K. i wsp.: Preservation of pancreatic beta-cell function and prevention of type 2 diabetes mellitus by pharmacological treatment of insulin resistance in high risk hispanic women. Diabetes, 2002, 51, 9, 2796-2803.
6. Burke J.P., Williams K., Venkat Narayan K.M. i wsp.: A population perspective on diabetes prevention, whom should we target for preventing weight gain? Diabetes Care, 2003, 26, 7, 1999-2004.
7. Chiasson J.L., Josse R.G., Gomis R. i wsp.: Acarbose for prevention of type 2 diabetes. The STOP-NIDDM randomised trial. Lancet, 2002, 359, 9323, 2072-2077.
8. Coustan D.R., Carpenter M.W., O'Sullivan P.S. i wsp.: Gestational diabetes, Predictors of subsequent disordered glucose metabolism. Am. J. Obstet. Gynecol,. 1993, 168, 4, 1139-1144.
9. Damm P.: Gestational diabetes mellitus and subsequent development of overt diabetes mellitus. Dan. Med. Bull, 1998, 45, 5, 495-509.
10. Damm P., Kuhl C., Bertelsen A. i wsp.: Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus. Am. J. Obstet. Gynecol., 1992, 167, 3, 607-616.
11. Damm P., Kuhl C., Hornnes P., i wsp.: A longitudinal study of plasma insulin and glucagon in women with previous gestational diabetes. Diabetes Care, 1995, 18, 5, 654-665.
12. Edelstein S.L., Knowler W.C., Bain R.P. i wsp.: Predictors of progression from impaired glucose tolerance to NIDDM. Diabetes, 1997, 46, 4, 701-710.
13. Effendic S., Hanson U., Persson B. i wsp.: Glucose tolerance, insulin release, und insulin sensitivity in normal-weight women with previous gestational diabetes mellitus. Diabetes, 1987, 36, 413-419.
14. Grant P.T., Oats J.N., Beischer NA.: The long-term follow-up of women with gestational diabetes. Aust. NZJ Obstet. Gynaecol., 1986, 26, 1, 17-22.
15. Greenberg L.R., Moore T.R., Murphy H.: Gestational diabetes mellitus. Antenatal variables as predictors of postpartum glucose intolerance. Obstet. Gynecol., 1995, 86, 1, 97-101.
16. Haffner S.: Tne importance of hyperglicemia in the non fasting state to the development of cardiovascular disease. Endocr. Rev., 1998, 19, 5, 583-592.
17. Meyers-Seifer C.H., Vohr B.R.: Lipid levels in former gestational diabetic mothers. Diabetes Care, 1996, 19, 12, 1351-1356.
18. Kjos S.L., Buchanan T.A., Greenspoon J.S. i wsp.: Gestational diabetes mellitus. The prevalence of glucose intolerance and diabetes mellitus in the first two months post partum. Am. J. Obstet. Gynecol., 1990, 163, 1, 93-98.
19. Knowler W.C., Barret-Connor E., Fowler S.E. i wsp.: Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med., 2002, 346, 6, 393-403.
20. Metzger B.E., Cho N.H., Roston S.M. i wsp.: Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care, 1993, 16, 12, 1598-1605.
21. Pallardo F., Herranz L., Garcia-lngelmo T. i wsp.: Early postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care, 1999, 2, 2, 7, 1053-1058.
22. Reaven G.M., Chen Y.D.I., Hollenbeck C.B. i wsp.: Plasma insulin, c-peptide, and proinsulin concentrations in obese and nonobese Individuals with varying degrees of glucose tolerance. J. Clin. Endocrinol. Metab., 1993, 76, 1, 44-48.
23. Tominaga M., Eguchi H., Manaka H. i wsp.: Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care, 1999, 22, 6, 920-924.
24. Tuomilehto J., Lindstrom J., Eriksson J.G. i wsp.: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med., 2001, 344, 18, 1343-1350.
25. Ward W.K., Johnston C.L., Beard J.C. i wsp.: Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus. Diabetes, 1985, 34, 9, 861-869.
26. The DECODE Study Group. Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia, 2003, 46, 608-621.